Alzheimer’s Research Papers Feb 2001

Alzheimer’s Research Papers

            

Allen SJ, Robertson AG, Tyler SJ, Wilcock GK, Dawbarn D. Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterisation of binding to infusion pumps. J Biochem Biophys Methods. 2001 Feb 26;47(3):239-55.

Richard E, Lemstra AW, Walstra GJ, van Gool WA. [Evaluation of the therapeutic effects in individual patients with Alzheimer disease] Ned Tijdschr Geneeskd. 2001 Feb 24;145(8):340-5.

Lambert JC, Mann D, Goumidi L, Harris J, Amouyel P, Iwatsubo T, Lendon C, Chartier-Harlin MC. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet. 2001 Feb 24;357(9256):608-9.

Queralt R, Ezquerra M, Castellví M, Lleó A, Blesa R, Oliva R. Detection of the presenilin 1 gene mutation (M139T) in early-onset familial Alzheimer disease in Spain. Neurosci Lett. 2001 Feb 23;299(3):239-41.

Tomidokoro Y, Ishiguro K, Harigaya Y, Matsubara E, Ikeda M, Park JM, Yasutake K, Kawarabayashi T, Okamoto K, Shoji M. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci Lett. 2001 Feb 23;299(3):169-72.

Kadoyama K, Takahashi Y, Higashida H, Tanabe T, Yoshimoto T. Cyclooxygenase-2 stimulates production of amyloid beta-peptide in neuroblastoma x glioma hybrid NG108-15 cells. Biochem Biophys Res Commun. 2001 Feb 23;281(2):483-90.

Rodrigues CM, Solá S, Brito MA, Brondino CD, Brites D, Moura JJ. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem Biophys Res Commun. 2001 Feb 23;281(2):468-74.

Heron P, Cousins K, Boyd C, Daya S. Paradoxical effects of copper and manganese on brain mitochondrial function. Life Sci. 2001 Feb 23;68(14):1575-83.

Konno T. Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril. Biochemistry. 2001 Feb 20;40(7):2148-54.

Soriano S, Kang DE, Fu M, Pestell R, Chevallier N, Zheng H, Koo EH. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol. 2001 Feb 19;152(4):785-94.

Doyu M, Sawada K, Mitsuma N, Niwa J, Yoshimoto M, Fujii Y, Sobue G, Kato K. Gene expression profile in Alzheimer's brain screened by molecular indexing. Brain Res Mol Brain Res. 2001 Feb 19;87(1):1-11.

Sudol M, Sliwa K, Russo T. Functions of WW domains in the nucleus. FEBS Lett. 2001 Feb 16;490(3):190-5.

Kálmán J, Kudchodkar BJ, Krishnamoorthy R, Dory L, Lacko AG, Agarwal N. High cholesterol diet down regulates the activity of activator protein-1 but not nuclear factor-kappa B in rabbit brain. Life Sci. 2001 Feb 16;68(13):1495-503.

Engidawork E, Gulesserian T, Yoo BC, Cairns N, Lubec G. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun. 2001 Feb 16;281(1):84-93.

Kakimura J, Kitamura Y, Taniguchi T, Shimohama S, Gebicke-Haerter PJ. Bip/GRP78-induced production of cytokines and uptake of amyloid-beta(1-42) peptide in microglia. Biochem Biophys Res Commun. 2001 Feb 16;281(1):6-10.

Rösler N, Wichart I, Jellinger KA. Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer's disease patients. Neurosci Lett. 2001 Feb 16;299(1-2):117-20.

Nacmias B, Tedde A, Cellini E, Forleo P, Orlacchio A, Guarnieri BM, Petruzzi C, D'Andrea F, Serio A, Sorbi S. Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 2001 Feb 16;299(1-2):9-12. , ,

Kim JH, Anwyl R, Suh YH, Djamgoz MB, Rowan MJ. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J Neurosci. 2001 Feb 15;21(4):1327-33.

Combs CK, Karlo JC, Kao SC, Landreth GE. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci. 2001 Feb 15;21(4):1179-88.

Santacruz KS, Swagerty D. Early diagnosis of dementia. Am Fam Physician. 2001 Feb 15;63(4):703-13, 717-8.

Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med. 2001 Feb 15;30(4):433-46.

Jhoo JH, Kim KW, Lee DY, Lee KU, Lee JH, Kim SY, Youn JY, Youn JC, Woo JI. Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans. J Neurol Sci. 2001 Feb 15;184(1):21-5. , ,

Van Leuven F, Thiry E, Lambrechts M, Stas L, Boon T, Bruynseels K, Muls E, Descamps O. Sequencing of the coding exons of the LRP1 and LDLR genes on individual DNA samples reveals novel mutations in both genes. Atherosclerosis. 2001 Feb 15;154(3):567-77.

Chabot S, Charlet D, Wilson TL, Yong VW. Cytokine production consequent to T cell--microglia interaction: the PMA/IFN gamma-treated U937 cells display similarities to human microglia. J Neurosci Methods. 2001 Feb 15;105(2):111-20.

Picklo MJ, Montine TJ. Acrolein inhibits respiration in isolated brain mitochondria. Biochim Biophys Acta. 2001 Feb 14;1535(2):145-52.

Farrer LA. Intercontinental epidemiology of Alzheimer disease: a global approach to bad gene hunting. JAMA. 2001 Feb 14;285(6):796-8.

Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, Gao S, Evans RM, Ogunseyinde AO, Adeyinka AO, Musick B, Hui SL. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001 Feb 14;285(6):739-47.

 

Goldman WP, Price JL, Storandt M, Grant EA, McKeel DW, Rubin EH, Morris JC. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology. 2001 Feb 13;56(3):361-7. ,

 

Woodruff-Pak DS, Vogel RW, Wenk GL. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94.

Kovács T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport. 2001 Feb 12;12(2):285-8.

McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 2001 Feb 10;357(9254):436-9. ,

Maimone D, Dominici R, Grimaldi LM. Pharmacogenomics of neurodegenerative diseases. Eur J Pharmacol. 2001 Feb 9;413(1):11-29.

Ho L, Guo Y, Spielman L, Petrescu O, Haroutunian V, Purohit D, Czernik A, Yemul S, Aisen PS, Mohs R, Pasinetti GM. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett. 2001 Feb 9;298(3):191-4.

Burke WJ, Li SW, Zahm DS, Macarthur H, Kolo LL, Westfall TC, Anwar M, Glickstein SB, Ruggiero DA. Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo. Brain Res. 2001 Feb 9;891(1-2):218-27.

Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, Diamond DM. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 2001 Feb 9;891(1-2):42-53.

Yamazaki T, Chang TY, Haass C, Ihara Y. Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J Biol Chem. 2001 Feb 9;276(6):4454-60.

 

Steinhilb ML, Turner RS, Gaut JR. The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase. J Biol Chem. 2001 Feb 9;276(6):4476-84.

Creemers JW, Ines Dominguez D, Plets E, Serneels L, Taylor NA, Multhaup G, Craessaerts K, Annaert W, De Strooper B. Processing of beta-secretase by furin and other members of the proprotein convertase family. J Biol Chem. 2001 Feb 9;276(6):4211-7.

Nakamura T, Yamashita H, Takahashi T, Nakamura S. Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125. Biochem Biophys Res Commun. 2001 Feb 2;280(4):1085-92.

Ohkubo N, Mitsuda N, Tamatani M, Yamaguchi A, Lee YD, Ogihara T, Vitek MP, Tohyama M. Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J Biol Chem. 2001 Feb 2;276(5):3046-53.

Kahle PJ, Haass C. The emerging utility of animal models of chronic neurodegenerative diseases. Expert Opin Ther Targets. 2001 Feb;5(1):125-32.

Cheon MS, Bajo M, Gulesserian T, Cairns N, Lubec G. Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease. Electrophoresis. 2001 Feb;22(3):445-8.

Ludolph AC, Sperfeld A, Collatz BM, Storch A. [Tauopathies--a new class of neurodegenerative diseases] Nervenarzt. 2001 Feb;72(2):78-85.

Bell EE, Chenery HJ, Ingram JC. Semantic priming in Alzheimer's dementia: evidence for dissociation of automatic and attentional processes. Brain Lang. 2001 Feb;76(2):130-44.

Sogawa CA, Asanuma M, Sogawa N, Miyazaki I, Nakanishi T, Furuta H, Ogawa N. Localization, regulation, and function of metallothionein-III/growth inhibitory factor in the brain. Acta Med Okayama. 2001 Feb;55(1):1-9.

D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 2001 Feb;38(2):120-34.

Lund ET, McKenna R, Evans DB, Sharma SK, Mathews WR. Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry. J Neurochem. 2001 Feb;76(4):1221-32.

Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB. beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem. 2001 Feb 1;76(4):1121-8.

Levkovitz Y, Bloch Y, Kaplan D, Diskin A, Abramovitchi I. Fluvoxamine for psychosis in Alzheimer's disease. J Nerv Ment Dis. 2001 Feb;189(2):126-9.

Heneka MT, Landreth GE, Feinstein DL. Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease. Ann Neurol. 2001 Feb;49(2):276.

Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, Mufson EJ. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol. 2001 Feb;49(2):202-13.

 

Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE, Masliah E, Galasko D, Trojanowski JQ, Lee VM. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol. 2001 Feb;49(2):165-75. ,

Gong CX, Lidsky T, Wegiel J, Grundke-Iqbal I, Iqbal K. Metabolically active rat brain slices as a model to study the regulation of protein phosphorylation in mammalian brain. Brain Res Brain Res Protoc. 2001 Feb;6(3):134-40.

Yamada T, Hattori H, Miura A, Tanabe M, Yamori Y. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci. 2001 Feb;55(1):21-5.

Russo C, Salis S, Dolcini V, Venezia V, Song XH, Teller JK, Schettini G. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Neurobiol Dis. 2001 Feb;8(1):173-80.

Chung CW, Song YH, Kim IK, Yoon WJ, Ryu BR, Jo DG, Woo HN, Kwon YK, Kim HH, Gwag BJ, Mook-Jung IH, Jung YK. Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol Dis. 2001 Feb 1;8(1):162-72.

Shepherd CE, Thiel E, McCann H, Halliday GM. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease. Neurobiol Dis. 2001 Feb;8(1):136-46.

Cha JH, Farrell LA, Ahmed SF, Frey A, Hsiao-Ashe KK, Young AB, Penney JB, Locascio JJ, Hyman BT, Irizarry MC. Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein. Neurobiol Dis. 2001 Feb;8(1):90-102.

DeKroon RM, Armati PJ. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiol Dis. 2001 Feb;8(1):78-89.

Van den Haute C, Spittaels K, Van Dorpe J, Lasrado R, Vandezande K, Laenen I, Geerts H, Van Leuven F. Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice. Neurobiol Dis. 2001 Feb 1;8(1):32-44.

 

Ditaranto K, Tekirian TL, Yang AJ. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis. 2001 Feb;8(1):19-31.

Singh N, Talalayeva Y, Tsiper M, Romanov V, Dranovsky A, Colflesh D, Rudamen G, Vitek MP, Shen J, Yang X, Goldgaber D, Schwarzman AL. The role of Alzheimer's disease-related presenilin 1 in intercellular adhesion. Exp Cell Res. 2001 Feb 1;263(1):1-13.

Crawford FC, Freeman MJ, Schinka JA, Morris MD, Abdullah LI, Richards D, Sevush S, Duara R, Mullan MJ. Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene. Exp Neurol. 2001 Feb;167(2):456-9. ,

Lauer D, Reichenbach A, Birkenmeier G. Alpha 2-macroglobulin-mediated degradation of amyloid beta 1--42: a mechanism to enhance amyloid beta catabolism. Exp Neurol. 2001 Feb;167(2):385-92.

Freir DB, Holscher C, Herron CE. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol. 2001 Feb;85(2):708-13.

Galton CJ, Gomez-Anson B, Antoun N, Scheltens P, Patterson K, Graves M, Sahakian BJ, Hodges JR. Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):165-73.

Calderon J, Perry RJ, Erzinclioglu SW, Berrios GE, Dening TR, Hodges JR. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):157-64.

Lambon Ralph MA, Powell J, Howard D, Whitworth AB, Garrard P, Hodges JR. Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review. J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):149-56.

Dalrymple-Alford J. Comparative neuropsychology of Lewy body and Alzheimer's dementia. J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):148.

Foster JK. Selective attention in Alzheimer's disease. Front Biosci. 2001 Feb 1;6:D135-53.

Guise S, Braguer D, Carles G, Delacourte A, Briand C. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J Neurosci Res. 2001 Feb 1;63(3):257-67.

Temple V, Jozsvai E, Konstantareas MM, Hewitt TA. Alzheimer dementia in Down's syndrome: the relevance of cognitive ability. J Intellect Disabil Res. 2001 Feb;45(Pt 1):47-55.

Brown AM, Sheu RK, Mohs R, Haroutunian V, Blass JP. Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA). J Mol Neurosci. 2001 Feb;16(1):41-8.

Dannhardt G, Kiefer W. Cyclooxygenase inhibitors--current status and future prospects. Eur J Med Chem. 2001 Feb;36(2):109-26.

Parks JK, Smith TS, Trimmer PA, Bennett JP, Parker WD. Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem. 2001 Feb;76(4):1050-6.

Skaddan MB, Kilbourn MR, Snyder SE, Sherman PS. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors. J Cereb Blood Flow Metab. 2001 Feb;21(2):144-8.

Wigley WC, Stidham RD, Smith NM, Hunt JF, Thomas PJ. Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. Nat Biotechnol. 2001 Feb;19(2):131-6.

Fletcher L. Vaccine tests key Alzheimer's disease hypothesis. Nat Biotechnol. 2001 Feb;19(2):104-5.

Liu SJ, Crum RM, Anthony JC. A latent variable approach to studying risk factors for Alzheimer's disease. Neuroepidemiology. 2001 Feb;20(1):31-9.

Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM. Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology. 2001 Feb;20(1):7-15.

Heun R, Papassotiropoulos A, Jessen F, Maier W, Breitner JC. A family study of Alzheimer disease and early- and late-onset depression in elderly patients. Arch Gen Psychiatry. 2001 Feb;58(2):190-6.

Cooper DB, Epker M, Lacritz L, Weine M, Rosenberg RN, Honig L, Cullum CM. Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol. 2001 Feb;15(1):125-8.

Wynick D, Thompson SW, McMahon SB. The role of galanin as a multi-functional neuropeptide in the nervous system. Curr Opin Pharmacol. 2001 Feb;1(1):73-7.

Li Y, Cam J, Bu G. Low-density lipoprotein receptor family: endocytosis and signal transduction. Mol Neurobiol. 2001 Feb;23(1):53-67.

Strubel D, Jacquot JM, Martin-Hunyadi C. [Dementia and falls] Ann Readapt Med Phys. 2001 Feb;44(1):4-12.

Riederer BM, Mourton-Gilles C, Frey P, Delacourte A, Probst A. Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease. J Neurocytol. 2001 Feb;30(2):145-58.

Garcia ML, Cleveland DW. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. Curr Opin Cell Biol. 2001 Feb;13(1):41-8.

Marques AR, Straus SE, Fahle G, Weir S, Csako G, Fischer SH. Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol. 2001 Feb;7(1):82-3.

Parnetti L, Lanari A, Amici S, Gallai V, Vanmechelen E, Hulstaert F, Phospho-Tau International Study Group. CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. Neurol Sci. 2001 Feb;22(1):77-8. ,

Vielhaber E, Virshup DM. Casein kinase I: from obscurity to center stage. IUBMB Life. 2001 Feb;51(2):73-8.

Kawahara M, Kuroda Y. Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol. Cell Mol Neurobiol. 2001 Feb;21(1):1-13.

García-López MT, Guardado-Santervás P. [Clinical study of patients with Alzheimer's disease under treatment with tacrine] Rev Neurol. 2001 Feb 16-28;32(4):394-7.

Myagkova MA, Gavrilova SI, Lermontova NN, Kalyn YB, Selezneva ND, Zharikov GA, Kolykhalov IV, Abramenko TV, Serkova TP, Bachurin SO. Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type. Bull Exp Biol Med. 2001 Feb;131(2):127-9.

Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VM. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol. 2001 Feb 1;158(2):555-62. ,

Barger SW, Basile AS. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem. 2001 Feb 1;76(3):846-54.

Kuperstein F, Reiss N, Koudinova N, Yavin E. Biphasic modulation of protein kinase C and enhanced cell toxicity by amyloid beta peptide and anoxia in neuronal cultures. J Neurochem. 2001 Feb;76(3):758-67.

Kato K, Inaguma Y, Ito H, Iida K, Iwamoto I, Kamei K, Ochi N, Ohta H, Kishikawa M. Ser-59 is the major phosphorylation site in alphaB-crystallin accumulated in the brains of patients with Alexander's disease. J Neurochem. 2001 Feb;76(3):730-6.

Counts SE, Lah JJ, Levey AI. The regulation of presenilin-1 by nerve growth factor. J Neurochem. 2001 Feb;76(3):679-89.

Guo Z, Fratiglioni L, Viitanen M, Lannfelt L, Basun H, Fastbom J, Winblad B. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? Am J Epidemiol. 2001 Feb 1;153(3):225-31.

  

Christie RH, Bacskai BJ, Zipfel WR, Williams RM, Kajdasz ST, Webb WW, Hyman BT. Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy. J Neurosci. 2001 Feb 1;21(3):858-64.

 

Pigino G, Pelsman A, Mori H, Busciglio J. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J Neurosci. 2001 Feb 1;21(3):834-42.

Hedin HL, Eriksson S, Fowler CJ. Human platelet calcium mobilisation in response to beta-amyloid (25-35): buffer dependency and unchanged response in Alzheimer's disease. Neurochem Int. 2001 Feb;38(2):145-51.

Kerokoski P, Soininen H, Pirttilä T. Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality. Neurochem Int. 2001 Feb;38(2):127-34.

Szczepanik AM, Funes S, Petko W, Ringheim GE. IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol. 2001 Feb 1;113(1):49-62.

Chinnery PF, Taylor GA, Howell N, Brown DT, Parsons TJ, Turnbull DM. Point mutations of the mtDNA control region in normal and neurodegenerative human brains. Am J Hum Genet. 2001 Feb;68(2):529-32.

Massi F, Straub JE. Energy landscape theory for Alzheimer's amyloid beta-peptide fibril elongation. Proteins. 2001 Feb 1;42(2):217-29.

Bartolucci C, Perola E, Pilger C, Fels G, Lamba D. Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs. Proteins. 2001 Feb 1;42(2):182-91.

Petrie EC, Peskind ER, Dobie DJ, Veith RC, Raskind MA. Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging. Psychoneuroendocrinology. 2001 Feb;26(2):147-64.

Senanarong V, Harnphadungkit K, Lertrit P, Mitrpant C, Udompunthurak S, Limwong C, Prayoonwiwat N, Poungvarin N. Experience of ApoE study in Thai elderly. J Med Assoc Thai. 2001 Feb;84(2):182-7.

de la Monte SM, Wands JR. Alzheimer-associated neuronal thread protein-induced apoptosis and impaired mitochondrial function in human central nervous system-derived neuronal cells. J Neuropathol Exp Neurol. 2001 Feb;60(2):195-207. ,

Ma KC. Alzheimer-type I astrogliopathy (AIA) and its implications for dynamic plasticity of astroglia: a historical review of the significance of AIA. J Neuropathol Exp Neurol. 2001 Feb;60(2):121-31.

Kemper TL, Blatt GJ, Killiany RJ, Moss MB. Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys. Acta Neuropathol (Berl). 2001 Feb;101(2):145-53.

Patocka J, Strunecká A, Rípová D. [Cholinesterases and their importance in the etiology, diagnosis and therapy of Alzheimer's disease] Cesk Fysiol. 2001 Feb;50(1):4-10.

Ashford JW, Schmitt FA. Modeling the time-course of alzheimer dementia. Curr Psychiatry Rep. 2001 Feb;3(1):20-8.

van Dyck CH. Neuroimaging in alzheimer's disease: relevance for treatment. Curr Psychiatry Rep. 2001 Feb;3(1):13-9.

Ventura M, Sternon J. [Anticholinesterases in Alzheimer's disease] Rev Med Brux. 2001 Feb;22(1):43-9.

Huse JT, Doms RW. Neurotoxic traffic: uncovering the mechanics of amyloid production in Alzheimer's disease. Traffic. 2001 Feb;2(2):75-81.

Aviel-Ronen S, Shalmon B, Nass D. [Alzheimer disease and estrogen--the connection, modes of influence and the therapy] Harefuah. 2001 Feb;140(2):139-43.

Black SE, Patterson C, Feightner J. Preventing dementia. Can J Neurol Sci. 2001 Feb;28 Suppl 1:S56-66.

Chertkow H, Bergman H, Schipper HM, Gauthier S, Bouchard R, Fontaine S, Clarfield AM. Assessment of suspected dementia. Can J Neurol Sci. 2001 Feb;28 Suppl 1:S28-41.

Feldman H, Kertesz A. Diagnosis, classification and natural history of degenerative dementias. Can J Neurol Sci. 2001 Feb;28 Suppl 1:S17-27.

Pryse-Phillips W, Sternberg S, Rochon P, Naglie G, Strong H, Feightner J. The use of medications for cognitive enhancement. Can J Neurol Sci. 2001 Feb;28 Suppl 1:S108-14.

Trojanowski JQ, Lee . Brain degeneration linked to J Alzheimer’s Disease. 2001 Feb;3(1):117-119. Abstract

Strohmeyer R, Rogers J. Molecular and cellular mediators of Alzheimer's disease inflammation. J Alzheimers Dis. 2001 Feb;3(1):131-157.

Masliah E. Recent advances in the understanding of the role of synaptic proteins in Alzheimer's Disease and other neurodegenerative disorders. J Alzheimers Dis. 2001 Feb;3(1):121-129.

Trojanowski JQ, Lee VM. Brain degeneration linked to "fatal attractions" of proteins in Alzheimer's disease and related disorders. J Alzheimers Dis. 2001 Feb;3(1):117-119.

Hardy J. The genetic causes of neurodegenerative diseases. J Alzheimers Dis. 2001 Feb;3(1):109-116.

Nixon RA, Mathews PM, Cataldo AM. The neuronal endosomal-lysosomal system in Alzheimer's disease. J Alzheimers Dis. 2001 Feb;3(1):97-107.

Gambetti P, Parchi P, Capellari S, Russo C, Tabaton M, Teller JK, Chen SG. Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other conformational diseases. J Alzheimers Dis. 2001 Feb 1;3(1):87-95.

Masters CL, Beyreuther K. Henryk M. Wisniewski and the amyloid theory of Alzheimer's disease. J Alzheimers Dis. 2001 Feb;3(1):83-86.

Selkoe DJ. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis. 2001 Feb;3(1):75-80.

Ghiso J, Frangione B. Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia. J Alzheimers Dis. 2001 Feb;3(1):65-73.

Bancher C. From counting neurons to the preclinical diagnosis of Alzheimer's disease. J Alzheimers Dis. 2001 Feb;3(1):59-63.

Wegiel J, Bobinski M, Tarnawski M, Dziewiatkowski J, Popovitch E, Bobinski M, Lach B, Reisberg B, Miller DC, De Santi S, De Leon MJ. Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease. J Alzheimers Dis. 2001 Feb;3(1):49-57.

Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. J Alzheimers Dis. 2001 Feb;3(1):41-48.

Ji Y, Permanne B, Sigurdsson EM, Holtzman DM, Wisniewski T. Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. J Alzheimers Dis. 2001 Feb;3(1):23-30.

Iverson GL. Interpreting change on the WAIS-III/WMS-III in clinical samples. Arch Clin Neuropsychol. 2001 Feb;16(2):183-91.

Hulse RE, Winterfield J, Kunkler PE, Kraig RP. Astrocytic clasmatodendrosis in hippocampal organ culture. Glia. 2001 Feb;33(2):169-79.

Yang J, Feng G, Zhang J, Hui Z, Breen G, St Clair D, He L. Is ApoE gene a risk factor for vascular dementia in Han Chinese? Int J Mol Med. 2001 Feb;7(2):217-9.

Campbell A, Hamai D, Bondy SC. Differential toxicity of aluminum salts in human cell lines of neural origin: implications for neurodegeneration. Neurotoxicology. 2001 Feb;22(1):63-71.

Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Hu XS, Takeda A, Itoh M, Sasaki H. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Feb;25(2):447-56.

Hoogendijk WJ, Meynen G, Feenstra MG, Eikelenboom P, Kamphorst W, Swaab DF. [Increased activity of stress-regulating systems in Alzheimer disease] Tijdschr Gerontol Geriatr. 2001 Feb;32(1):17-23.

Nishiyama N. Thymectomy-induced deterioration of learning and memory. Cell Mol Biol (Noisy-le-grand). 2001 Feb;47(1):161-5.

Reilly CE. Neprilysin content is reduced in Alzheimer brain areas. J Neurol. 2001 Feb;248(2):159-60.

Wang X, Luedecking EK, Minster RL, Ganguli M, DeKosky ST, Kamboh MI. Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. Hum Genet. 2001 Feb;108(2):105-8. , ,

Clostre F. [Mitochondria: recent pathophysiological discoveries and new therapeutic perspectives] Ann Pharm Fr. 2001 Feb;59(1):3-21.

Seidl R, Cairns N, Singewald N, Kaehler ST, Lubec G. Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology. Naunyn Schmiedebergs Arch Pharmacol. 2001 Feb;363(2):139-45.

Rojas-Fernandez CH. Successful use of donepezil for the treatment of dementia with Lewy bodies. Ann Pharmacother. 2001 Feb;35(2):202-5.

Dumery L, Bourdel F, Soussan Y, Fialkowsky A, Viale S, Nicolas P, Reboud-Ravaux M. beta-Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease. Pathol Biol (Paris). 2001 Feb;49(1):72-85.

Mercer JF. The molecular basis of copper-transport diseases. Trends Mol Med. 2001 Feb;7(2):64-9.

Coyle J, Kershaw P. Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. Biol Psychiatry. 2001 Feb 1;49(3):289-99.

Maelicke A, Samochocki M, Jostock R, Fehrenbacher A, Ludwig J, Albuquerque EX, Zerlin M. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Biol Psychiatry. 2001 Feb 1;49(3):279-88.

Newhouse PA, Potter A, Kelton M, Corwin J. Nicotinic treatment of Alzheimer's disease. Biol Psychiatry. 2001 Feb 1;49(3):268-78.

Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry. 2001 Feb 1;49(3):258-67.

Zeng H, Zhang Y, Peng L, Shao H, Menon NK, Yang J, Salomon AR, Freidland RP, Zagorski MG. Nicotine and amyloid formation. Biol Psychiatry. 2001 Feb 1;49(3):248-57.

Seo J, Kim S, Kim H, Park CH, Jeong S, Lee J, Choi SH, Chang K, Rah J, Koo J, Kim E, Suh Y. Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity. Biol Psychiatry. 2001 Feb 1;49(3):240-7.

Shimohama S, Kihara T. Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity. Biol Psychiatry. 2001 Feb 1;49(3):233-9.

Zamani MR, Allen YS. Nicotine and its interaction with beta-amyloid protein: a short review. Biol Psychiatry. 2001 Feb 1;49(3):221-32.

Volkow ND, Ding YS, Fowler JS, Gatley SJ. Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia. Biol Psychiatry. 2001 Feb 1;49(3):211-20.